CRISM'
Price
Prix
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de CRISM' ?
Quel est le bénéfice par action (BPA) de CRISM' ?
Quelles sont les évaluations des analystes et le prix cible de l'action CRISM' ?
Quel est l'EBITDA de CRISM' ?
Quel est le flux de trésorerie disponible de CRISM' ?
Quel est le flottant des actions de CRISM' ?
Finances
- Capitalisation boursière
- 1,87 M
- BPA (TTM)
- -0,0203 $US
- Free Float
- 8,66 M
- EBITDA (TTM)
- -889,00 k
- Cash-flow disponible (TTM)
- -933,00 k
Cotation
- 52W span
- 0,0643 $US0,394 $US
Notes des analystes
L'objectif de prix est de 1,581 et l'action est analysée par 1 analystes.
Acheter
1
Hold
0
Vendre
0
Informations
CRISM Therapeutics Corp. is a biotechnology company, which engages in the development of cancer treatment drugs for solid tumors. It offers ChemoSeed product which is a biodegradable drug delivery technology designed for the delivery of chemotherapy directly into cancer tissue. Its services include formulation and consultancy. It operates through the Head Office and Scientific Research segments. The Head Office segment focuses on the administrative in nature and undertaken from the United Kingdom. The Scientific Research segment relates to the work being undertaken on its key research program, ChemoSeed for glioma, and any income associated with it in the form of grants or consultancy. The company was founded in March 2016 and is headquartered in Road Town, British Virgin Islands.
- Industries
- Services commerciaux divers
- Secteur
- Soins de santé
Identifiant
- ISIN
- VGG042401262
- Ticker primaire
- CRTX